Tower Research Capital (TRC)’s Molecular Partners MOLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$176 Buy
+45
New +$186 ﹤0.01% 5693

Other funds holding MOLN

Tower Research Capital (TRC)'s MOLN Position: Q3 2026 in Review

Tower Research Capital (TRC) opened a new position in Molecular Partners (MOLN) in Q3 2026: 45 shares worth $176. The stake represents ﹤0.01% of the portfolio and ranks #5693 among its holdings.

7 funds tracked by Wall St. Rank hold MOLN as of Q3 2026.

  • Tower Research Capital (TRC) held 45 shares of Molecular Partners worth $176 as of Q3 2026.
  • Molecular Partners was a new Tower Research Capital (TRC) position in Q3 2026.
  • Molecular Partners made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5693 holding.
  • 7 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.